| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3390/MICROARRAYS3030168 |
| P8608 | Fatcat ID | release_b325wppkfvfmdp7nyuyjhrr33q |
| P932 | PMC publication ID | 4996361 |
| P698 | PubMed publication ID | 27600342 |
| P5875 | ResearchGate publication ID | 268362646 |
| P50 | author | Jörg Jäkel | Q53441074 |
| P2093 | author name string | Edgar Dahl | |
| Laura Huth | |||
| P2860 | cites work | Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay | Q21090079 |
| Global cancer statistics | Q22241238 | ||
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 | ||
| Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array | Q24648335 | ||
| Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology | Q24681980 | ||
| Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for the detection of K-ras mutations. | Q54325730 | ||
| Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer | Q56601042 | ||
| Seromic profiling of colorectal cancer patients with novel glycopeptide microarray | Q57195324 | ||
| RAF/RAS oncogenes and mismatch-repair status | Q57281056 | ||
| CpG island methylator phenotype in cancer | Q81080870 | ||
| Systemic treatment of colorectal cancer | Q81253030 | ||
| Molecular Genetics of Colorectal Cancer | Q82521439 | ||
| K-ras mutations and benefit from cetuximab in advanced colorectal cancer. | Q27851454 | ||
| Blinded by the Light: The Growing Complexity of p53 | Q29547590 | ||
| ras genes | Q29547799 | ||
| Detection of circulating tumor DNA in early- and late-stage human malignancies | Q29615778 | ||
| Knowledge and attitudes of primary healthcare patients regarding population-based screening for colorectal cancer. | Q31031268 | ||
| Genomic and epigenetic instability in colorectal cancer pathogenesis | Q33836026 | ||
| The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer. | Q34084873 | ||
| Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. | Q34139666 | ||
| Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer | Q34321215 | ||
| A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study | Q34407192 | ||
| Gene expression anti-profiles as a basis for accurate universal cancer signatures | Q34454251 | ||
| Tumor suppressor functions of miR-133a in colorectal cancer. | Q34748993 | ||
| Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle | Q34760306 | ||
| Diagnostic and prognostic microRNAs in stage II colon cancer. | Q34803800 | ||
| Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue | Q35083591 | ||
| Automation of biochip array technology for quality results | Q36322917 | ||
| MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients | Q36480448 | ||
| A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency | Q36494964 | ||
| Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review | Q36966177 | ||
| A colorectal cancer classification system that associates cellular phenotype and responses to therapy | Q37175913 | ||
| Toward a comprehensive and systematic methylome signature in colorectal cancers | Q37445275 | ||
| MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization | Q37700483 | ||
| Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer | Q38360381 | ||
| Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions | Q39166874 | ||
| Clinical applications using digital PCR. | Q40185104 | ||
| Biological and clinical importance of the p53 tumor suppressor gene. | Q41006256 | ||
| Clinical implications of the p53 gene | Q41036383 | ||
| Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis | Q41737680 | ||
| SNaPshot and StripAssay as valuable alternatives to direct sequencing for KRAS mutation detection in colon cancer routine diagnostics. | Q42075151 | ||
| Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer | Q43292375 | ||
| Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma | Q43439313 | ||
| Microsatellite instability and colorectal cancer prognosis. | Q46831092 | ||
| Diagnostic microRNA markers to screen for sporadic human colon cancer in blood. | Q47381718 | ||
| Multitarget stool DNA testing for colorectal-cancer screening | Q48331668 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 168-179 | |
| P577 | publication date | 2014-06-26 | |
| P1433 | published in | Microarrays (Basel, Switzerland) | Q27724777 |
| P1476 | title | Molecular Diagnostic Applications in Colorectal Cancer | |
| P478 | volume | 3 |
Search more.